Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.06
Delayed Data
As of Feb 24
 +0.03 / +0.37%
Today’s Change
5.77
Today|||52-Week Range
9.88
-5.95%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.03
Today’s open7.94
Day’s range7.91 - 8.15
Volume285,849
Average volume (3 months)307,988
Market cap$632.8M
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.04-0.41%
FMIFoundation Medicine ...-0.15-0.65%
NVTAInvitae Corp-0.04-0.39%
PTIProteostasis Therape...-0.04-0.27%
Data as of 4:02pm ET, 02/24/2017

Financials

Last reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs